Cargando…

Transcription factor E3 renal cell carcinoma presenting as secondary hypertension

Microphthalmia-associated transcription factor family (transcription factor E3 or transcription factor EB) translocation renal cell carcinomas (RCCs) are rare neoplasms. These renal neoplasms can be either asymptomatic and incidentally discovered on imaging or symptomatic, with the most common prese...

Descripción completa

Detalles Bibliográficos
Autores principales: Mukendi, Alain Mwamba, Mataruka, Gerald Tatenda, Nadimpalli, Ramesh, Kasapato, Tshisola Miji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487286/
https://www.ncbi.nlm.nih.gov/pubmed/37692137
http://dx.doi.org/10.1097/CU9.0000000000000108
_version_ 1785103203326492672
author Mukendi, Alain Mwamba
Mataruka, Gerald Tatenda
Nadimpalli, Ramesh
Kasapato, Tshisola Miji
author_facet Mukendi, Alain Mwamba
Mataruka, Gerald Tatenda
Nadimpalli, Ramesh
Kasapato, Tshisola Miji
author_sort Mukendi, Alain Mwamba
collection PubMed
description Microphthalmia-associated transcription factor family (transcription factor E3 or transcription factor EB) translocation renal cell carcinomas (RCCs) are rare neoplasms. These renal neoplasms can be either asymptomatic and incidentally discovered on imaging or symptomatic, with the most common presenting symptoms being hematuria, pain, and abdominal mass, or paraneoplastic event. In conventional RCCs, hypertension is considered a risk factor and a possible paraneoplastic event, whereas, in translocation RCCs, prior exposure to cytotoxic chemotherapy is the only known risk factor, and hypertension as an isolated associated paraneoplastic event has never been reported. Interestingly, hypertension as the only presenting symptom in RCC is extremely rare. We report a case of transcription factor E3 positive RCC in a young adult presenting only with hypertension that normalized after radical nephrectomy. To the best of our knowledge, this is the first reported case of hypertension secondary to microphthalmia-associated transcription translocation RCC.
format Online
Article
Text
id pubmed-10487286
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104872862023-09-09 Transcription factor E3 renal cell carcinoma presenting as secondary hypertension Mukendi, Alain Mwamba Mataruka, Gerald Tatenda Nadimpalli, Ramesh Kasapato, Tshisola Miji Curr Urol Special Topic: Advances in Renal Cell Carcinoma Therapy: Case Report Microphthalmia-associated transcription factor family (transcription factor E3 or transcription factor EB) translocation renal cell carcinomas (RCCs) are rare neoplasms. These renal neoplasms can be either asymptomatic and incidentally discovered on imaging or symptomatic, with the most common presenting symptoms being hematuria, pain, and abdominal mass, or paraneoplastic event. In conventional RCCs, hypertension is considered a risk factor and a possible paraneoplastic event, whereas, in translocation RCCs, prior exposure to cytotoxic chemotherapy is the only known risk factor, and hypertension as an isolated associated paraneoplastic event has never been reported. Interestingly, hypertension as the only presenting symptom in RCC is extremely rare. We report a case of transcription factor E3 positive RCC in a young adult presenting only with hypertension that normalized after radical nephrectomy. To the best of our knowledge, this is the first reported case of hypertension secondary to microphthalmia-associated transcription translocation RCC. Lippincott Williams & Wilkins 2023-03 2022-08-02 /pmc/articles/PMC10487286/ /pubmed/37692137 http://dx.doi.org/10.1097/CU9.0000000000000108 Text en Copyright © 2022 The Authors. Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Special Topic: Advances in Renal Cell Carcinoma Therapy: Case Report
Mukendi, Alain Mwamba
Mataruka, Gerald Tatenda
Nadimpalli, Ramesh
Kasapato, Tshisola Miji
Transcription factor E3 renal cell carcinoma presenting as secondary hypertension
title Transcription factor E3 renal cell carcinoma presenting as secondary hypertension
title_full Transcription factor E3 renal cell carcinoma presenting as secondary hypertension
title_fullStr Transcription factor E3 renal cell carcinoma presenting as secondary hypertension
title_full_unstemmed Transcription factor E3 renal cell carcinoma presenting as secondary hypertension
title_short Transcription factor E3 renal cell carcinoma presenting as secondary hypertension
title_sort transcription factor e3 renal cell carcinoma presenting as secondary hypertension
topic Special Topic: Advances in Renal Cell Carcinoma Therapy: Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487286/
https://www.ncbi.nlm.nih.gov/pubmed/37692137
http://dx.doi.org/10.1097/CU9.0000000000000108
work_keys_str_mv AT mukendialainmwamba transcriptionfactore3renalcellcarcinomapresentingassecondaryhypertension
AT matarukageraldtatenda transcriptionfactore3renalcellcarcinomapresentingassecondaryhypertension
AT nadimpalliramesh transcriptionfactore3renalcellcarcinomapresentingassecondaryhypertension
AT kasapatotshisolamiji transcriptionfactore3renalcellcarcinomapresentingassecondaryhypertension